• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ZMYND8 调控的甲羟戊酸途径赋予 YAP 高表达的肠道癌细胞代谢脆弱性。

The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability.

机构信息

CAS Key Laboratory of Tissue Microenvironment and Tumor, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Nutrition and Health, Shanghai Jiao Tong University School of Medicine (SJTUSM) & Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China.

CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China.

出版信息

Mol Cell. 2021 Jul 1;81(13):2736-2751.e8. doi: 10.1016/j.molcel.2021.04.009. Epub 2021 Apr 30.

DOI:10.1016/j.molcel.2021.04.009
PMID:33932349
Abstract

Cholesterol metabolism is tightly associated with colorectal cancer (CRC). Nevertheless, the clinical benefit of statins, the inhibitor of cholesterol biogenesis mevalonate (MVA) pathway, is inconclusive, possibly because of a lack of patient stratification criteria. Here, we describe that YAP-mediated zinc finger MYND-type containing 8 (ZMYND8) expression sensitizes intestinal tumors to the inhibition of the MVA pathway. We show that the oncogenic activity of YAP relies largely on ZMYND8 to enhance intracellular de novo cholesterol biogenesis. Disruption of the ZMYND8-dependent MVA pathway greatly restricts the self-renewal capacity of Lgr5 intestinal stem cells (ISCs) and intestinal tumorigenesis. Mechanistically, ZMYND8 and SREBP2 drive the enhancer-promoter interaction to facilitate the recruitment of Mediator complex, thus upregulating MVA pathway genes. Together, our results establish that the epigenetic reader ZMYND8 endows YAP-high intestinal cancer with metabolic vulnerability.

摘要

胆固醇代谢与结直肠癌(CRC)密切相关。然而,胆固醇生物合成甲羟戊酸(MVA)途径抑制剂他汀类药物的临床获益尚不确定,可能是因为缺乏患者分层标准。在这里,我们描述了 YAP 介导的锌指 MYND 型包含 8 (ZMYND8)表达使肠道肿瘤对 MVA 途径抑制敏感。我们表明,YAP 的致癌活性在很大程度上依赖于 ZMYND8 来增强细胞内从头胆固醇生物合成。破坏依赖 ZMYND8 的 MVA 途径极大地限制了 Lgr5 肠干细胞(ISCs)的自我更新能力和肠道肿瘤发生。在机制上,ZMYND8 和 SREBP2 驱动增强子-启动子相互作用,从而促进中介复合物的募集,从而上调 MVA 途径基因。总之,我们的结果表明,表观遗传阅读器 ZMYND8 赋予 YAP 高肠道癌代谢脆弱性。

相似文献

1
The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability.ZMYND8 调控的甲羟戊酸途径赋予 YAP 高表达的肠道癌细胞代谢脆弱性。
Mol Cell. 2021 Jul 1;81(13):2736-2751.e8. doi: 10.1016/j.molcel.2021.04.009. Epub 2021 Apr 30.
2
Metabolic control of YAP and TAZ by the mevalonate pathway.甲羟戊酸途径对 YAP 和 TAZ 的代谢调控。
Nat Cell Biol. 2014 Apr;16(4):357-66. doi: 10.1038/ncb2936. Epub 2014 Mar 23.
3
Restriction of intestinal stem cell expansion and the regenerative response by YAP.YAP 限制肠道干细胞的扩增和再生反应。
Nature. 2013 Jan 3;493(7430):106-10. doi: 10.1038/nature11693. Epub 2012 Nov 25.
4
KIF11 manipulates SREBP2-dependent mevalonate cross talk to promote tumor progression in pancreatic ductal adenocarcinoma.KIF11 调控 SREBP2 依赖性甲羟戊酸代谢物对话促进胰腺导管腺癌的肿瘤进展。
Cancer Med. 2022 Sep;11(17):3282-3295. doi: 10.1002/cam4.4683. Epub 2022 May 26.
5
Statins inhibit blastocyst formation by preventing geranylgeranylation.他汀类药物通过阻止香叶基香叶基化来抑制胚泡形成。
Mol Hum Reprod. 2016 May;22(5):350-63. doi: 10.1093/molehr/gaw011. Epub 2016 Feb 7.
6
Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.他汀类药物可抑制失活Hippo信号通路的恶性间皮瘤细胞,并阻断YAP/CD44生长刺激轴。
Cancer Lett. 2017 Jan 28;385:215-224. doi: 10.1016/j.canlet.2016.10.020. Epub 2016 Oct 20.
7
Regulation of ZMYND8 to Treat Cancer.ZMYND8 的调控与癌症治疗。
Molecules. 2021 Feb 18;26(4):1083. doi: 10.3390/molecules26041083.
8
Dual histone reader ZMYND8 inhibits cancer cell invasion by positively regulating epithelial genes.双重组蛋白阅读器ZMYND8通过正向调控上皮基因抑制癌细胞侵袭。
Biochem J. 2017 May 19;474(11):1919-1934. doi: 10.1042/BCJ20170223.
9
RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway.RARγ 下调通过解除 Hippo-Yap 通路的抑制作用促进结直肠肿瘤发生和转移。
Cancer Res. 2016 Jul 1;76(13):3813-25. doi: 10.1158/0008-5472.CAN-15-2882. Epub 2016 Jun 20.
10
Chromatin reader ZMYND8 is a key target of all trans retinoic acid-mediated inhibition of cancer cell proliferation.染色质读码器 ZMYND8 是全反式视黄酸介导的抑制癌细胞增殖的关键靶标。
Biochim Biophys Acta Gene Regul Mech. 2017 Apr;1860(4):450-459. doi: 10.1016/j.bbagrm.2017.02.004. Epub 2017 Feb 14.

引用本文的文献

1
RACK7 senses and fine-tunes enhancer activity.RACK7可感知并微调增强子活性。
iScience. 2025 Jul 9;28(8):113083. doi: 10.1016/j.isci.2025.113083. eCollection 2025 Aug 15.
2
Hippo/YAP signaling pathway in colorectal cancer: regulatory mechanisms and potential drug exploration.结直肠癌中的Hippo/YAP信号通路:调控机制与潜在药物探索
Front Oncol. 2025 Jun 19;15:1545952. doi: 10.3389/fonc.2025.1545952. eCollection 2025.
3
Unlocking the lipid code: SREBPs as key drivers in gastrointestinal tumour metabolism.破解脂质密码:固醇调节元件结合蛋白作为胃肠道肿瘤代谢的关键驱动因素
Lipids Health Dis. 2025 May 24;24(1):190. doi: 10.1186/s12944-025-02612-8.
4
ZMYND8 Reads H3K36me2 to Activate CEBPE Transcription and Suppress Multiple Myeloma Progression through the Inhibition of Adaptive UPR Pathways.ZMYND8 通过读取 H3K36me2 来激活 CEBPE 转录,并通过抑制适应性未折叠蛋白反应(UPR)途径来抑制多发性骨髓瘤进展。
Adv Sci (Weinh). 2025 May;12(20):e2409219. doi: 10.1002/advs.202409219. Epub 2025 May 10.
5
SREBP2 as a central player in cancer progression: potential for targeted therapeutics.SREBP2作为癌症进展的核心因素:靶向治疗的潜力
Front Pharmacol. 2025 Apr 16;16:1535691. doi: 10.3389/fphar.2025.1535691. eCollection 2025.
6
ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27.ZMYND8通过对IL-27的脂质调控驱动乳腺癌中的HER2抗体耐药性。
Nat Commun. 2025 Apr 25;16(1):3908. doi: 10.1038/s41467-025-59184-5.
7
The RBM39 degrader indisulam inhibits acute megakaryoblastic leukemia by altering the alternative splicing of ZMYND8.RBM39降解剂茚地西胺通过改变ZMYND8的可变剪接来抑制急性巨核细胞白血病。
Cell Biosci. 2025 Apr 13;15(1):46. doi: 10.1186/s13578-025-01380-3.
8
Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer.靶向组蛋白阅读器ZMYND8可抑制抗雄激素诱导的前列腺癌神经内分泌肿瘤转分化。
Nat Cancer. 2025 Apr;6(4):629-646. doi: 10.1038/s43018-025-00928-z. Epub 2025 Mar 18.
9
The Role of Yes-Associated Protein in Inflammatory Diseases and Cancer.Yes相关蛋白在炎症性疾病和癌症中的作用。
MedComm (2020). 2025 Mar 10;6(3):e70128. doi: 10.1002/mco2.70128. eCollection 2025 Mar.
10
Patient-derived xenograft model in cancer: establishment and applications.癌症患者来源的异种移植模型:建立与应用
MedComm (2020). 2025 Jan 19;6(2):e70059. doi: 10.1002/mco2.70059. eCollection 2025 Feb.